{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:17:58Z","timestamp":1770232678989,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.drugpo.2014.07.004","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T17:01:42Z","timestamp":1405443702000},"page":"78-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1211-9709","authenticated-orcid":false,"given":"Hanna","family":"Uosukainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam R.","family":"Winstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2014.07.004_bib0005","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0010","series-title":"DSM-V development","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/002204260803800207","article-title":"Poly-drug use among ecstasy users: Separate, synergistic, and indiscriminate patterns","volume":"38","author":"Boeri","year":"2008","journal-title":"Journal of Drug Issues"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000253550","article-title":"Can the severity of dependence scale be usefully applied to \u2018ecstasy\u2019?","volume":"60","author":"Bruno","year":"2009","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0025","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1177\/0269881110378370","article-title":"Instability of the ecstasy market and a new kid on the block: Mephedrone","volume":"25","author":"Brunt","year":"2011","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1360-0443.2009.02649.x","article-title":"Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: A cross-national study","volume":"104","author":"Cottler","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hup.343","article-title":"Ecstasy abuse and dependence among adolescents and young adults: Applicability and reliability of DSM-IV criteria","volume":"16","author":"Cottler","year":"2001","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0149-7634(85)90022-3","article-title":"New concepts in cocaine addiction: The dopamine depletion hypothesis","volume":"9","author":"Dackis","year":"1985","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0045","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3109\/10826080902848566","article-title":"Patterns of ecstasy use and associated harm: Results of a Brazilian online survey","volume":"44","author":"de Almeida","year":"2009","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2009.09.009","article-title":"Is ecstasy a drug of dependence?","volume":"107","author":"Degenhardt","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0055","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1081\/JA-200066777","article-title":"Recent trends in the use of \u201cclub drugs\u201d: An Australian review","volume":"40","author":"Degenhardt","year":"2005","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.drugpo.2007.08.007","article-title":"The epidemiology of GHB and ketamine use in an Australian household survey","volume":"19","author":"Degenhardt","year":"2008","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1515\/revneuro-2012-0078","article-title":"The role of setting for ketamine abuse: Clinical and preclinical evidence","volume":"23","author":"De Luca","year":"2012","journal-title":"Reviews in the Neurosciences"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0070","series-title":"Annual report 2011, The State of the Drugs Problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2011"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0075","series-title":"Annual report 2012, The state of drugs problem in Europe","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2012"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/1064-1297.16.1.1","article-title":"In vivo pharmacology of MDMA and its enantiomers in rhesus monkeys","volume":"16","author":"Fantegrossi","year":"2008","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0085","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1126\/science.2011738","article-title":"Cocaine addiction: Psychology and neurophysiology","volume":"251","author":"Gawin","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4 Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"The Journal Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0095","series-title":"Drugs misuse declared: Findings from the 2011\/12 Crime Survey for England and Wales","author":"Home Office Statistics","year":"2012"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0100","series-title":"IBM SPSS Advanced Statistics 21","author":"IBM Corporation","year":"2012"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/02791072.2001.10400480","article-title":"The nonmedical use of ketamine, part two: A review of problem use and dependence","volume":"33","author":"Jansen","year":"2001","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0110","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerging Health Threats Journal"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0115","first-page":"CD003023","article-title":"Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders","volume":"3","author":"Knapp","year":"2007","journal-title":"Cochrane Database Systematic Reviews"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0120","series-title":"Neurobiology of addiction","first-page":"69","article-title":"Psychostimulants","author":"Koob","year":"2006"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0125","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1081\/JA-200066936","article-title":"Patterns of polydrug use among ketamine injectors in New York City","volume":"40","author":"Lankenau","year":"2005","journal-title":"Substance Use and Misuse"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","article-title":"Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)","volume":"115","author":"Lopez-Quintero","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/S0140-6736(09)61420-3","article-title":"Effectiveness of community treatments for heroin and crack cocaine addiction in England: A prospective, in-treatment cohort study","volume":"374","author":"Marsden","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0140","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1360-0443.2005.001127.x","article-title":"Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom","volume":"100","author":"McCambridge","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0145","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: A multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0150","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/sj.npp.1300681","article-title":"Risk of becoming cocaine dependent: Epidemiological estimates for the United States, 2000\u20132001","volume":"30","author":"O\u2019Brien","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0155","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1111\/j.1360-0443.2006.01611.x","article-title":"The empirical basis of substance use disorders diagnosis: Research recommendations for the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V)","volume":"101","author":"Schuckit","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1741-7015-9-119","article-title":"Novel pharmacotherapeutic treatments for cocaine addiction","volume":"9","author":"Shorter","year":"2011","journal-title":"BMC Medicine"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0165","series-title":"Australian trends in ecstasy and related drug markets 2012: Findings from the Ecstasy and Related Drugs Reporting System (EDRS). Australian Drug Trend Series No. 100","author":"Sindicich","year":"2013"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0306-4603(99)00013-1","article-title":"Drug use and drinking among students in 36 countries","volume":"25","author":"Smart","year":"2000","journal-title":"Addictive Behaviours"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0175","series-title":"Drug Misuse Declared: Findings from the 2010\/11 British Crime Survey. Home Office Statistics","author":"Smith","year":"2011"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2006.08.008","article-title":"Who is becoming hallucinogen dependent soon after hallucinogen use starts?","volume":"87","author":"Stone","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2003.09.001","article-title":"The external validity of results derived from ecstasy users recruited using purposive sampling strategies","volume":"73","author":"Topp","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0190","series-title":"World Drug Report 2012","first-page":"1","author":"United Nations Office on Drugs and Crime","year":"2012"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0376-8716(01)00195-8","article-title":"Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults\u2014A transient phenomenon?. Results from a longitudinal community study","volume":"66","author":"von Sydow","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"Winstock","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0376-8716(00)00215-5","article-title":"Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK","volume":"64","author":"Winstock","year":"2001","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0210","series-title":"Mephedrone: Assessment of health risks and harms. Appendix 1 to Annex 1 (Technical report on mephedrone)","author":"Winstock","year":"2010"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0215","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1360-0443.2010.03130.x","article-title":"Mephedrone, new kid for the chop?","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0220","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(10)62021-1","article-title":"Mephedrone: Still available and twice the price","volume":"376","author":"Winstock","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0225","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1360-0443.2011.03502.x","article-title":"Mephedrone: Use, subjective effects and health risks","volume":"106","author":"Winstock","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0230","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pnpbp.2012.04.020","article-title":"Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity","volume":"39","author":"Wood","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0235","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/15563650.2010.531021","article-title":"Case series of individuals with analytically confirmed acute mephedrone toxicity","volume":"48","author":"Wood","year":"2010","journal-title":"Clinical Toxicology"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0240","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/10550490802269064","article-title":"Hallucinogen use disorders among adult users of MDMA and other hallucinogens","volume":"17","author":"Wu","year":"2008","journal-title":"American Journal of Addiction"},{"key":"10.1016\/j.drugpo.2014.07.004_bib0245","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/NMD.0b013e3181568625","article-title":"Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents","volume":"195","author":"Yen","year":"2007","journal-title":"The Journal of Nervous and Mental Disease"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395914001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:42:21Z","timestamp":1760629341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395914001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0955395914001728"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.07.004","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}